权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Genetics and Genomics Core

遗传学和基因组学核心

基本信息

批准号：
10406874
负责人：
ALISON M GOATE
金额：
$ 36.59万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-05-01 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10406874
关键词：
Aging Alleles Alzheimer&apos s Disease Alzheimer&apos s disease related dementia Amyloid beta-Protein Apolipoprotein E Autopsy Basic Science Biocompatible Materials Biological Markers Blood Blood Banks Blood specimen Brain Classification Clinic Clinical Clinical Sciences Cognitive Collection Communities Consent DNA Data Data Collection Databases Dementia Deposition Disease Dose Etiology Funding Genes Genetic Genetic Diseases Genetic Polymorphism Genome Genomic approach Genomics Genotype Goals Human Resources Individual Informatics International Investigation Laboratory Research Longitudinal Studies Measures Mentorship Participant Pathogenesis Pathologic Peripheral Peripheral Blood Mononuclear Cell Persons Plasma Play Proteome Proteomics PubMed Quality Control Rare Diseases Research Research Methodology Research Personnel Research Training Resource Allocation Risk Factors Role Sampling Students Tissues Training Tube United States National Library of Medicine Variant base blood-based biomarker cohort demented early onset education research exome exome sequencing genetic analysis genetic risk factor genome wide association study genomic data insight neuropathology next generation sequencing novel novel marker outreach programs recruit tau Proteins whole genome

项目摘要

Mount Sinai ADRC (Sano): Genetics and Genomics Core (Core F) – Research Summary One hundred years ago dementing illnesses were classified based upon their clinical presentation and neuropathology. The promise of the twenty first century is that we will be able to classify these same diseases by the genetic cause or genetic risk factors, a classification based upon etiology not symptomatology. During the last three decades many genes have been shown to cause autosomal dominant forms of early onset dementing illnesses. These rare disorders have provided enormous insight into the pathogenesis of more common variants of the same diseases. In 1993, a polymorphism in the apolipoprotein E (APOE) gene was identified as the first genetic risk factor for AD. A dose-dependent effect of the APOE4 allele has now become an important variable in all studies of AD. During the last ten years genome-wide association studies and next generation sequencing studies have begun to identify many novel risk factors for AD. The goal of the Genetics and Genomics Core of the ISMMS ADRC is to provide genetic data and biospecimens on all ADRC participants. We will obtain blood samples on ADRC participants. One blood sample will be sent to NCRAD, where it will be available to the entire community and will be included in national AD Genetics initiatives such as ongoing genome-wide association studies (GWAS) and whole genome/exome sequencing projects. The second tube will be retained locally. For DNA. Plasma and APOE genotype will also be available on all ADRC participants. Many participants will also have GWAS, exome array and/or whole exome/genome sequence data through national and international initiatives and ADRC affiliated projects. This data will be stored in the master ISMMS ADRC database and provided to investigators upon request. The Core will support projects and other cores as well as ADRC affiliated ageing and dementia projects. New in this application, we will begin to bank PBMCs and pilot plasma biomarker collection to enable novel biomarker programs in peripheral tissues.

西奈山ADRC (Sano)：遗传学和基因组学核心（核心F） -研究总结